title: Reactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable.
authors.affiliation: Division of Gastroenterology and Hepatology, University of Michigan Health System, 3110G Taubman Center, SPC 5368, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA. aslok@umich.edu
authors.forename: Anna S F
authors.initials: AS
authors.lastname: Lok
authors.forename: John W
authors.initials: JW
authors.lastname: Ward
authors.forename: Robert P
authors.initials: RP
authors.lastname: Perrillo
authors.forename: Brian J
authors.initials: BJ
authors.lastname: McMahon
authors.forename: T Jake
authors.initials: TJ
authors.lastname: Liang
mesh_terms: D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B / Q000821:virology*; D006510:Hepatitis B Antibodies / Q000097:blood; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000821:virology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008403:Mass Screening; D012307:Risk Factors; D014775:Virus Activation
chemical_list: D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens